GLAXF
Price
$19.64
Change
+$0.05 (+0.26%)
Updated
Aug 27 closing price
Capitalization
79.39B
OPHLY
Price
$3.71
Change
+$0.10 (+2.77%)
Updated
Aug 28 closing price
Capitalization
5.28B
62 days until earnings call
Interact to see
Advertisement

GLAXF vs OPHLY

Header iconGLAXF vs OPHLY Comparison
Open Charts GLAXF vs OPHLYBanner chart's image
GSK
Price$19.64
Change+$0.05 (+0.26%)
Volume$1.72K
Capitalization79.39B
Ono Pharmaceutical
Price$3.71
Change+$0.10 (+2.77%)
Volume$277.32K
Capitalization5.28B
GLAXF vs OPHLY Comparison Chart in %
Loading...
GLAXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OPHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLAXF vs. OPHLY commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLAXF is a Buy and OPHLY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (GLAXF: $19.64 vs. OPHLY: $3.71)
Brand notoriety: GLAXF and OPHLY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GLAXF: 150% vs. OPHLY: 110%
Market capitalization -- GLAXF: $80.35B vs. OPHLY: $5.28B
GLAXF [@Pharmaceuticals: Major] is valued at $80.35B. OPHLY’s [@Pharmaceuticals: Major] market capitalization is $5.28B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $656.17B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $88.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLAXF’s FA Score shows that 1 FA rating(s) are green whileOPHLY’s FA Score has 1 green FA rating(s).

  • GLAXF’s FA Score: 1 green, 4 red.
  • OPHLY’s FA Score: 1 green, 4 red.
According to our system of comparison, both GLAXF and OPHLY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLAXF’s TA Score shows that 6 TA indicator(s) are bullish while OPHLY’s TA Score has 6 bullish TA indicator(s).

  • GLAXF’s TA Score: 6 bullish, 3 bearish.
  • OPHLY’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, GLAXF is a better buy in the short-term than OPHLY.

Price Growth

GLAXF (@Pharmaceuticals: Major) experienced а -1.31% price change this week, while OPHLY (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.84%. For the same industry, the average monthly price growth was +1.29%, and the average quarterly price growth was +11.90%.

Reported Earning Dates

OPHLY is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.84% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLAXF($79.4B) has a higher market cap than OPHLY($5.28B). GLAXF has higher P/E ratio than OPHLY: GLAXF (17.87) vs OPHLY (15.29). GLAXF YTD gains are higher at: 16.731 vs. OPHLY (6.609). OPHLY has higher annual earnings (EBITDA): 141B vs. GLAXF (8.61B). OPHLY has more cash in the bank: 181B vs. GLAXF (3.62B). GLAXF has less debt than OPHLY: GLAXF (17.4B) vs OPHLY (162B). OPHLY has higher revenues than GLAXF: OPHLY (484B) vs GLAXF (31.6B).
GLAXFOPHLYGLAXF / OPHLY
Capitalization79.4B5.28B1,503%
EBITDA8.61B141B6%
Gain YTD16.7316.609253%
P/E Ratio17.8715.29117%
Revenue31.6B484B7%
Total Cash3.62B181B2%
Total Debt17.4B162B11%
FUNDAMENTALS RATINGS
GLAXF vs OPHLY: Fundamental Ratings
GLAXF
OPHLY
OUTLOOK RATING
1..100
3067
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
3
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5561
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OPHLY's Valuation (3) in the null industry is in the same range as GLAXF (6). This means that OPHLY’s stock grew similarly to GLAXF’s over the last 12 months.

OPHLY's Profit vs Risk Rating (100) in the null industry is in the same range as GLAXF (100). This means that OPHLY’s stock grew similarly to GLAXF’s over the last 12 months.

OPHLY's SMR Rating (100) in the null industry is in the same range as GLAXF (100). This means that OPHLY’s stock grew similarly to GLAXF’s over the last 12 months.

GLAXF's Price Growth Rating (55) in the null industry is in the same range as OPHLY (61). This means that GLAXF’s stock grew similarly to OPHLY’s over the last 12 months.

GLAXF's P/E Growth Rating (100) in the null industry is in the same range as OPHLY (100). This means that GLAXF’s stock grew similarly to OPHLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GLAXFOPHLY
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
59%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
56%
Bullish Trend 2 days ago
52%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
51%
Advances
ODDS (%)
Bullish Trend 9 days ago
64%
Bullish Trend 2 days ago
51%
Declines
ODDS (%)
Bearish Trend 24 days ago
51%
Bearish Trend 4 days ago
64%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
57%
Aroon
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
GLAXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OPHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ANWPX71.890.32
+0.45%
American Funds New Perspective A
LLPFX25.00N/A
N/A
Longleaf Partners
FTQGX40.58N/A
N/A
Fidelity Focused Stock
GSVSX16.69N/A
N/A
Goldman Sachs Large Cap Value Svc
MDMIX27.21N/A
N/A
Madison Dividend Income I

GLAXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLAXF has been loosely correlated with GSK. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GLAXF jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLAXF
1D Price
Change %
GLAXF100%
N/A
GSK - GLAXF
37%
Loosely correlated
-1.18%
OPHLY - GLAXF
9%
Poorly correlated
+2.77%
HAWPF - GLAXF
8%
Poorly correlated
N/A
ORINY - GLAXF
6%
Poorly correlated
-0.36%
GIKLY - GLAXF
5%
Poorly correlated
N/A
More

OPHLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, OPHLY has been loosely correlated with OTSKY. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if OPHLY jumps, then OTSKY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPHLY
1D Price
Change %
OPHLY100%
+2.77%
OTSKY - OPHLY
42%
Loosely correlated
+0.38%
ALPMY - OPHLY
36%
Loosely correlated
+0.82%
CHGCY - OPHLY
26%
Poorly correlated
+1.76%
BAYRY - OPHLY
22%
Poorly correlated
-0.97%
OPHLF - OPHLY
14%
Poorly correlated
N/A
More